Skip to main content
. 2023 Feb 24;18(3):791–799. doi: 10.1007/s11739-023-03222-x

Table 3.

Types of IRRs occurred in CT-P10 and oRTX groups of patients

Reaction characteristics*, n (%) CT-P10 (n = 64) oRTX (n = 64)
Laryngeal paresthesia 19 (29.7) 21 (32.8)
Feeling of tightness in the chest 3 (4.7) 10 (15.6)
Drowsiness/weakness 9 (14.1) 4 (6.3)
Nausea 4 (6.3) 1 (1.6)
Itching in the ears 1 (1.6) 5 (7.8)
Sweating, cough, and redness 5 (7.8) 3 (4.7)

IRRs infusion-related reactions, oRTX originator rituximab

*More than one reaction was observed in one patient